Advertisement

Topics

Latest "Grubb & Ellis Company" News Stories - Page: 20

04:58 EST 15th December 2018 | BioPortfolio

Here are the most relevant search results for "Grubb & Ellis Company" found in our extensive news archives from over 250 global news sources.

More Information about Grubb & Ellis Company on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Grubb & Ellis Company for you to read. Along with our medical data and news we also list Grubb & Ellis Company Clinical Trials, which are updated daily. BioPortfolio also has a large database of Grubb & Ellis Company Companies for you to search.

Showing "Grubb Ellis Company" News Articles 476–500 of 19,000+

Thursday 6th December 2018

Bone Therapeutics SA BOTHE Medical Equipment Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryBone Therapeutics SA Bone Therapeutics is a cell therapy company that develops autologous and allogeneic cell therapy products. The company offers pipeline products such as PREOB, an autologous osteoblastic cell therapy product used for the treatment of osteonecrosis and nonunion fractures; and ALLOB, an allogeneic osteoblastic cell therapy product, for delayedunion fractures, spinal fusion...


Eppendorf 5415D Centrifuge w/ F45-24-11 Rotor & Lid, Working!

C $421.42 (0 Bids)End Date: Thursday Dec-13-2018 11:31:10 ESTBid now | Add to watch list Biotech365 : Eppendorf 5415D Centrifuge w/ F45-24-11 Rotor & Lid, Working! BioMarketplace You want to propose your products or a Biotech Company, a Biotech Tool … Continue reading →

Edeniq Defeats Aemetis’ Lawsuit

Edeniq, Inc. announced today that all of Aemetis’ remaining claims against the Company were dismissed on summary judgement. In the order granting Edeniq’s motion, Judge Peter H. Kirwan of the Santa Clara Superior Court ruled that Aemetis could not sustain a claim for breach of contract “because Aemetis did not deliver to Edeniq a commitment for finan...


AEON Global Health Announces Adjournment of Annual Meeting of Shareholders until January 16, 2019

Annual Meeting adjourned solely with respect to Proposal 4 – approval of an amendment to the Company’s Amended Certificate of Incorporation to continue to restrict certain transfers of its common stock in order to preserve the tax treatment of its … Continue reading →

Canopy Rivers Enhances European Platform With Further Investment in Italy

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES TORONTO, Dec. 06, 2018 (GLOBE NEWSWIRE) — Canopy Rivers Inc. (the “Company” or “Canopy Rivers”) (TSXV: RIV) is pleased to announce that it has increased its ownership stake in … Continue reading →

Abattis Announces Acquisition of Fertilizer Company NutriVida

VANCOUVER, British Columbia, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that it has signed a non-binding letter of intent dated December 6, 2018 (the “LOI”)  to acquire 100% interest in NutriVida Corp. (“NutriVida”) through an arm’s length transaction, a privately held fertilizer and n...

Covance Honored with Frost & Sullivan Asia Pacific Award for Fifth Consecutive Year

Awarded CRO 2018 Customer Value Leadership Award LabCorp® (NYSE: LH), a leading global life sciences company, today announced that its Covance Drug Development business (Covance) has been awarded the 2018 Frost & Sullivan Asia Pacific CRO Customer Value Leadership Award. The award reflects Covance’s continued commitment to its Asia Pacific custo...

OptiBiotix signs Greece, Cyprus distribution deal for SlimBiome Medical device

The Company has an established distribution network in Cyprus, Greece and the Middle East and a track record in taking new products to market direct to pharmacies through The post OptiBiotix signs Greece, Cyprus distribution deal for SlimBiome Medical device appeared first on Compelo Medical Devices.

Bristol-Myers Squibb Company (BMY) Citi 2018 Global Healthcare Brokers Conference (Transcript)

Global Cord Blood Corporation Announces Results of 2018 Annual General Meeting

HONG KONG, Dec. 6, 2018 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 2018 Annual General Meeting, which was held on December 5, 2018, in Hong Kong S.A.R., China. ...

Drug Company Actelion to Pay $360M in Kickback Probe

NewsThe U.S. attorney's office in Boston announced the settlement Thursday with Actelion Pharmaceuticals US Inc., which was acquired last year by Johnson & Johnson.

Savior Lifetec Corp 4167 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummarySavior Lifetec Corp SLC is an injectable manufacturer and distributor. The company offers active pharmaceutical ingredients APIs and finished dosage formulations. It provides sterile crystallization and aseptic processing of sterile powder. SLC offers carbapenem products, which include imipenem, meropenem, and ertapenem. The company's imipenem and cilastatin injection are used in treatment ...

Immupharma Plc IMM Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryImmuPharma Plc ImmuPharma develops novel drugs for the treatment of serious medical conditions with unmet medical need. ImmuPharma develops drugs for the treatment of lupus, cancer, moderate to severe pain, highly resistant hospitalacquired infections such as methicillinresistant staphylococcus aureus infection and inflammatory disorders including rheumatoid arthritis and asthma. The compan...

Actelion Is Third Company To Settle Charity Co-Pay Kickback Claims With DOJ

Company agrees to pay $360m to resolve allegations it used a charity as a conduit to pay Medicare patient copays...   

Factor Therapeutics Ltd FTT Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 17092018] Prices from USD $250

SummaryFactor Therapeutics Ltd FTL, formerly Tissue Therapies Ltd is a developer of wound care therapeutics. The company develops treatments for acute and chronic wound healing applications such as chronic skin ulcers and burns. Its lead therapeutic candidate, VF001 is a targeted growth factor which is being developed to treat venous leg ulcers. FTL offers cell culture reagents to enhance the grow...

Puma Biotechnology Presents Results from the HR-Positive Subgroup in Phase III Trial of Neratinib for HER2-Amplified, Early Stage Breast Cancer

LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced that results from the subgroup of patients with hormone receptor positive (HR-positive) breast cancer from the Company’s Phase III ExteNET Trial of neratinib for early stage HER2-Amplified breast cancer are being presented at the 2018 San Antonio Breast Cancer Symposium (SABCS)...

WuXi Biologics Wins SCRIP Award for "Best Company in an Emerging Market"

SHANGHAI and LONDON, Dec. 6, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company that offers end-to-end solutions for biologics discovery, development and manufacturing, today announced that it has won the SCRIP Award in the category of "Best Company in an Emerging Market". This award recognizes the rapid growth, significant a...

Hercules Capital Receives Stockholder Approval to Reduce Its Asset Coverage Requirement to 150%

Received a “For” Recommendation from both Institutional Shareholders Services Inc. (“ISS”) and Glass, Lewis & Co. Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today ...

Aptorum Group Limited Announces Pricing of Initial Public Offering

Aptorum Group Limited (“Aptorum”, or the “Company”), a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing therapeutic projects and diagnostic technologies to tackle unmet medical needs, today announced that on December 3, 2018, its registration statement on Form F-1, relating to a ...

Nuvectra Completes 3,000 U.S. Algovita SCS Implantations

Nuvectra (NASDAQ:NVTR), a neurostimulation medical device company, announced today that the Company’s Algovita Spinal Cord Stimulation (SCS) system has been implanted in over 3,000 patients in the U.S. As quoted in the press release:  The Algovita system utilizes patent-protected stretchable lead technology with a robust internal pulse generator to deliver four stimulation modes to patients fo...

Keryx Biopharmaceuticals Inc KERX Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryKeryx Biopharmaceuticals Inc Keryx develops and commercializes new therapies for the treatment of renal disease. The company's lead product Auryxia ferric citrate is an FDA approved oral, absorbable ironbased phosphate binder, which helps lower the amount of phosphate in human blood. Auryxia is used in the treatment of chronic kidney disease, renal diseases and iron deficiency anemia. This ...

Bioventix Plc - Result of AGM

Bioventix Plc - Result of AGM PR Newswire London, December 6 Bioventix plc ("Bioventix" or the "Company") Result of AGM Bioventix plc (AIM: BVXP) announces that at its Annual General Meeting ("AGM...

RTI Surgical Inc RTIX Medical Equipment Deals and Alliances Profile [Report Updated: 15102018] Prices from USD $250

SummaryRTI Surgical Inc RTI, formerly RTI Biologics Inc is a surgical implant company that offers biologic, metal and synthetic implants. The company's products include spine implants, surgical specialties, sports medicine implants, cardiothoracic and orthobiologics. It offers spine implants such as demineralized bone matrix powder, anterior cervical plate system, cancellous chips, cequence anteri...

Alliance Growers Announces its Contribution to Maximize Cannabis Industry Production and Provides Time-Line for its 2018 Annual Regulatory Filings

Vancouver, British Columbia--(Newsfile Corp. - December 6, 2018) - Alliance Growers Corp. (CSE: ACG) (FSE: 1LA) (WKN: A2DFYX) (OTCQB: ALGWF) ("Alliance" or "the Company") is pleased to announce how...

Enzo Biochem Schedules Teleconference to Discuss First Quarter 2019 Results Tuesday, December 11, 2018 at 8:30 AM E.T.

Enzo Biochem, Inc. (NYSE:ENZ), an integrated diagnostic and therapeutics company, will hold a conference call to discuss fiscal 2019 first quarter results Tuesday, December 11, 2018, at 8:30 AM E.T. To listen to the conference call dial 1-888-459-5609. International callers can dial 1-973-321-1024. When prompted, use PIN number 3927608. Dia...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks